Showing results (1631-1640 of 1,715) with videos related to
Sort By:
Pageof 172
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2026
Phosphorus enrichment does not enlarge the predicted CO<sub>2</sub> fertilization effect on forest carbon sequestrationBin Wang, He Lyu, Xueqian Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i>-Mutated or <i>KMT2A</i>-Rearranged AMLJoshua F Zeidner, Tara L Lin, Rina Li Welkie, et al.Blood Advances|November 21, 2025
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 StudyAndrew S Artz, Brent R Logan, Wael Saber, et al.BMC Genomics|December 16, 2010
Nucleotide diversity maps reveal variation in diversity among wheat genomes and chromosomesEduard D Akhunov, Alina R Akhunova, Olin D Anderson, et al.Physical Review Letters|March 16, 2007
Antimatter plasmas in a multipole trap for antihydrogenG Andresen, W Bertsche, A Boston, et al.Plos Genetics|October 30, 2016
PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of InheritanceSoto Romuald Kiando, Nathan R Tucker, Luis-Jaime Castro-Vega, et al.Haematologica|April 23, 2026
Phase Ib/II trial of anti-CD33 monoclonal antibody BI 836858 and azacitidine in previously untreated older acute myeloid leukemia patients: Beat AML S2 sub-study resultsMichael J Hochman, Amy S Ruppert, Ying Huang, et al.Blood Advances|March 18, 2025
Novel Composite Health Assessment Risk Model for Older Allogeneic Transplant Recipients: BMT-CTN 1704Mohamed L Sorror, Wael Saber, Brent R Logan, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021Daniel A Pollyea, Dale Bixby, Alexander Perl, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 15, 2019
Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in OncologyMartin S Tallman, Eunice S Wang, Jessica K Altman, et al.Pageof 172